Vetr Thinks Regeneron Is Looking Healthy By: Benzinga via Benzinga November 21, 2016 at 08:12 AM EST On Friday, the Vetr crowd upgraded their rating of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) from 4 stars (buy), issued two days ... Read More >> Related Stocks: Regeneron Pharmaceuticals Valeant Pharmaceuticals International, Inc.